The course focuses on engineering’s role in commercialization of vaccines and biologics. Biologics are more complex than small molecule drug products and present unique challenges in commercialization. This course includes an overview of vaccines and biologics from historical context, product, process and analytical technologies, immunology, clinical, regulatory and ethical considerations, economics, risk mitigation, and impact on human health.
Biproduct & Bioprocess Engineering
University of Virginia
Chemical and Life Science Engineering
Michael King, Blair Okita
4th year or higher CHE or BME standing or Instructor Permission